top of page

From Trial to Treatment

Stability Biologics logo horizontal YELLOW AND WHITE.png

CLINICAL TRIALS

Clinical Trials

STABLECAMP: Stability Biologics is currently conducting a multicenter, prospective, randomized controlled study using a modified multi-platform (Matriarch) design. This trial evaluates the efficacy of multiple cellular, acellular, and matrix-like products (CAMPs) combined with standard of care (SOC) versus SOC alone in the treatment of nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). This adaptive platform enables comparative analysis across diverse graft technologies and supports the inclusion of additional CAMPs over time.​

​

  • Products in the RCT include AmnioCore, Amnio Tri Core, Amnio Quad Core. AmnioCore Pro and AmnioCore Pro+

  • Click here to read more about our study on Clinicaltrials.gov

Peer Reviewed Publications​

​

  • Evaluation of cellular, acellular, and matrixlike products (CAMPs) in the management of nonhealing diabetic foot ulcers: an interim analysis of the STABLECAMP trial​

​

​

  • Evaluation of cellular, acellular, and matrix-like products in the management of nonhealing venous leg ulcers: an interim analysis of STABLECAMP

Hexagonal collage with diverse business themes_ teamwork, handshake, innovation. Includes

Interim Data Analysis

  • Presenting peer reviewed interim data analysis for STABLECAMP AmnioCore, Amnio Quad Core, and AmnioCore Pro in the management of DFUs and VLUs. 

  • Presenting peer reviewed retrospective data on the outcomes of MOHs micrographic surgery for non-melanoma (NMSC) using Amnio Tri Core. ​​

Tissue Regenerative Evidence Summit (TRES) October 30th New Orleans

International Post Acute Wound Summit (IPAWS) November 13-24 New Orleans

New York State Podiatric Medicine Association (NYSPMA) Clinical Conference January 22-25 

background6-01.png

Past Events ​

​

​

​​

bottom of page